Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis
Scientific Reports 10(1):1148, 2020
Mastiha (Pistacia Lentiscus) improves gut microbiota diversity, hepatic steatosis and disease activity in a biopsy-confirmed mouse model of advanced non-alcoholic steatohepatitis and fibrosis
Molecular Nutrition & Food Research 63(24):e1900927, 2019
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
World Journal of Gastroenterology 25(33):4904-4920, 2019
Hepatic molecular characteristics of patients with varying degrees of nonalcoholic steatohepatitis compared to healthy normal weight individuals
American Journal of Physiology - Gastroenterology and Liver Physiology 316(4):G462-G472, 2019
Disease progression and pharmacological intervention in a nutrient-deficient rat model of nonalcoholic steatohepatitis
Digestive Diseases and Sciences 64(5):1238-1256, 2019
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafbranor in diet-induced obese mouse models of biopsy-confrmed nonalcoholic steatohepatitis
World Journal of Gastroenterology 24(2):179–194, 2018
INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis
World Journal of Gastroenterology 24(2):195–210, 2018
Mouse models of nonalcoholic steatohepatitis in preclinical drug development
Drug Discovery Today 22(11):1707–1718, 2017